BPC157 Shows Promise in Combating Cancer Cachexia, Review Suggests

Cancer cachexia is a debilitating metabolic syndrome characterized by severe weight loss, muscle wasting, and adipose tissue depletion, profoundly impacting patient quality of life and prognosis. Current therapeutic options are often limited and ineffective, leaving a significant unmet medical need. This review article addresses the urgent need for novel interventions by exploring the potential of BPC157 to mitigate these devastating effects, specifically focusing on how this stable gastric pentadecapeptide might rescue patients from the catabolic processes underlying cachexia.